About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials in Houston | 461 Studies

Clinical Trials Colorectal CancerHouston

Colorectal Cancer Clinical Trials in Houston

Find 461 clinical trials for colorectal cancer near Houston, Texas. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 461 trials

Active not recruitingMicrowave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyThis study compares the outcomes and safety of two standard treatment options called microwave ablation and surgical wedge resection in patients with non-small cell lung cancer…NCT04430725·Houston, Texas CompletedStudy of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid TumorsThis is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti-lymphocyte activation gene-3 (LAG-3) antibody TSR-033 alone, in combination with the anti-PD-1…NCT03250832·Los Angeles, California and 11 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedHLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsThis is a data collection study, also referred to as a "screening" study; no investigational or standard therapy will be administered as part of this study.NCT05124743·Houston, Texas

RecruitingA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerThe purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to assess the recommended phase 2 combination dose (RP2CD) of…NCT05379595·Birmingham, Alabama and 52 others

CompletedA Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies.NCT05039177·Birmingham, Alabama and 13 others

CompletedValidation of Colon Biomarkers for the Early Detection of Colorectal AdenocarcinomaThe investigators are undertaking a multi-center, 13000 subject validation study of several biomarkers for early detection of colon cancer.NCT01511653·Boston, Massachusetts and 8 others

RecruitingA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerThe purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of…NCT07284849·Mobile, Alabama and 292 others

CompletedAn Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act NowThe primary objective is to confirm the specificity of a multi-target stool DNA test (mt-sDNA), Cologuard, in an average risk population, ages 45-49.NCT03728348·Phoenix, Arizona and 38 others

RecruitingPhase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPhase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.NCT06218914·Duarte, California and 17 others

CompletedStudy of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)This will be a randomized, open-label, multicenter, Phase II study with primary objectives to assess whether expression of select chemotherapy markers is associated with…NCT01374425·Birmingham, Alabama and 78 others

TerminatedVolatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C TrialVAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival…NCT04316013·Cleveland, Ohio and 26 others

TerminatedREVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor MalignanciesPatients received intratumoral (IT) injections of NKTR-262 in 3-week cycles for up to 3 cycles; bempegaldesleukin with or without nivolumab was administered every 3 weeks (q3w)…NCT03435640·Scottsdale, Arizona and 13 others

UnknownEnd of Life Treatment Preferences of Latino Medicare Beneficiaries With CancerObjectives: The primary objective of the research project is to investigate how declining health status influences the end-of-life (EOL) treatment preferences in Latino Medicare…NCT01389830·Houston, Texas

CompletedR-21 Colorectal Cancer Screening (CRCS) Pilot TrialThe goal of this study is to test patient education program for decision making about colorectal cancer (CRC) screening in community health centers.NCT01492049·Houston, Texas

Active not recruitingPhase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal CancerThis is a multi-center, non-randomised Phase 1b study to evaluate the safety and tolerability of ATP128 alone or in combination with BI 754091 and of heterologous prime-boost…NCT04046445·Scottsdale, Arizona and 11 others

TerminatedA Study of SC-007 in Subjects With Advanced CancerThis is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC-007 and consists of Part…NCT03253185·Los Angeles, California and 6 others

CompletedInitiation of Colon Cancer Screening in Veterans or "Start Screening Now"Initiation of colon cancer screening in veterans is a theory-based stepped intervention to increase first time colorectal cancer screening (CRCS) among male and female veterans…NCT01079533·Houston, Texas

CompletedA First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsThis is a Phase 1, first-in-human, open-label dose-escalation study to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) and assess the DLT of…NCT04045496·Denver, Colorado and 3 others

CompletedStudy of NS-9 in Patients With Liver MetastasesThis study is to investigate the safety of NS-9 and to see how well it is tolerated in patients with cancer that has metastasized (spread) to the liver from another primary tumor.NCT00094003·Lebanon, New Hampshire and 1 other

CompletedSotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationThe aim of the study is to compare progression-free survival (PFS) in previously treated participants with Kirsten rat sarcoma (KRAS) p.G12C mutated colorectal cancer (CRC)…NCT05198934·Birmingham, Alabama and 104 others

PreviousPage 2 of 24Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma